AGENDA
Erez Meltzer, Chief Executive Officer and Board member |
Opening remarks |
Erez Meltzer, Chief Executive Officer and Board member |
US go to market |
Ofir Koren, General Manager, ARC Division |
Global commercialization Regulatory pathway |
Dr. Orit Wimpfheimer, Chief Medical Officer |
Clinical benefits of the Nanonx.ARC Reimbursement Nanox.AI |
Erez Meltzer, Chief Executive Officer and Board member |
Innovation |
Jim Dara, GM Source & Services & Head of Nanox USA |
Source and services OEM |
Ran Daniel, Chief Financial Officer |
Financial highlights |
Erez Meltzer, Chief Executive Officer and Board member |
Closing remarks |
Q&A Session |